Morgan Stanley’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$818K Buy
401,862
+117,219
+41% +$239K ﹤0.01% 5211
2025
Q1
$464K Buy
284,643
+151,366
+114% +$247K ﹤0.01% 5361
2024
Q4
$244K Buy
133,277
+38,145
+40% +$69.8K ﹤0.01% 5715
2024
Q3
$550K Sell
95,132
-8,574
-8% -$49.6K ﹤0.01% 5357
2024
Q2
$838K Buy
103,706
+34,832
+51% +$281K ﹤0.01% 5068
2024
Q1
$956K Sell
68,874
-21,409
-24% -$297K ﹤0.01% 4969
2023
Q4
$553K Buy
90,283
+64,930
+256% +$397K ﹤0.01% 5578
2023
Q3
$118K Sell
25,353
-6,037
-19% -$28.2K ﹤0.01% 5801
2023
Q2
$168K Sell
31,390
-11,841
-27% -$63.4K ﹤0.01% 5716
2023
Q1
$425K Sell
43,231
-61,559
-59% -$606K ﹤0.01% 5347
2022
Q4
$1.96M Sell
104,790
-2,948
-3% -$55.2K ﹤0.01% 4479
2022
Q3
$2.23M Sell
107,738
-119,519
-53% -$2.47M ﹤0.01% 4354
2022
Q2
$4.72M Buy
227,257
+89,398
+65% +$1.86M ﹤0.01% 3822
2022
Q1
$5.94M Buy
137,859
+94,069
+215% +$4.05M ﹤0.01% 3492
2021
Q4
$2.62M Sell
43,790
-17,659
-29% -$1.06M ﹤0.01% 4355
2021
Q3
$5.28M Sell
61,449
-7,723
-11% -$664K ﹤0.01% 3626
2021
Q2
$7.69M Buy
69,172
+44,956
+186% +$5M ﹤0.01% 3295
2021
Q1
$2.7M Sell
24,216
-23,874
-50% -$2.66M ﹤0.01% 4021
2020
Q4
$5.11M Sell
48,090
-5,492
-10% -$583K ﹤0.01% 3234
2020
Q3
$7.46M Buy
53,582
+30,686
+134% +$4.27M ﹤0.01% 2313
2020
Q2
$7.41M Buy
22,896
+3,833
+20% +$1.24M ﹤0.01% 2262
2020
Q1
$1.7M Sell
19,063
-96,904
-84% -$8.65M ﹤0.01% 3498
2019
Q4
$4.59M Buy
115,967
+104,268
+891% +$4.13M ﹤0.01% 3289
2019
Q3
$287K Buy
11,699
+4,032
+53% +$98.9K ﹤0.01% 4949
2019
Q2
$271K Sell
7,667
-2,997
-28% -$106K ﹤0.01% 4884
2019
Q1
$477K Sell
10,664
-9,336
-47% -$418K ﹤0.01% 4568
2018
Q4
$960K Sell
20,000
-5,944
-23% -$285K ﹤0.01% 4307
2018
Q3
$1.73M Sell
25,944
-2,044
-7% -$136K ﹤0.01% 4125
2018
Q2
$1.32M Buy
27,988
+1,526
+6% +$71.8K ﹤0.01% 4427
2018
Q1
$1.5M Buy
26,462
+907
+4% +$51.2K ﹤0.01% 4250
2017
Q4
$1.27M Sell
25,555
-48,323
-65% -$2.4M ﹤0.01% 4385
2017
Q3
$5.62M Buy
73,878
+5,510
+8% +$419K ﹤0.01% 2844
2017
Q2
$6.43M Buy
68,368
+13,359
+24% +$1.26M ﹤0.01% 2594
2017
Q1
$4.37M Sell
55,009
-15,210
-22% -$1.21M ﹤0.01% 2988
2016
Q4
$5.85M Buy
70,219
+19,813
+39% +$1.65M ﹤0.01% 2833
2016
Q3
$5.64M Buy
50,406
+3,672
+8% +$411K ﹤0.01% 2548
2016
Q2
$5.18M Sell
46,734
-2,857
-6% -$317K ﹤0.01% 2587
2016
Q1
$5.18M Sell
49,591
-19,240
-28% -$2.01M ﹤0.01% 2495
2015
Q4
$5.55M Buy
68,831
+6,543
+11% +$528K ﹤0.01% 2566
2015
Q3
$4.32M Buy
62,288
+10,864
+21% +$753K ﹤0.01% 2788
2015
Q2
$5.04M Sell
51,424
-2,159
-4% -$211K ﹤0.01% 2788
2015
Q1
$5.25M Sell
53,583
-659
-1% -$64.5K ﹤0.01% 2711
2014
Q4
$5.98M Sell
54,242
-24,306
-31% -$2.68M ﹤0.01% 2555
2014
Q3
$9.28M Buy
78,548
+4,082
+5% +$482K ﹤0.01% 2097
2014
Q2
$9.66M Buy
74,466
+36,261
+95% +$4.7M ﹤0.01% 2067
2014
Q1
$6.11M Buy
38,205
+19,955
+109% +$3.19M ﹤0.01% 2379
2013
Q4
$2.54M Sell
18,250
-1,776
-9% -$247K ﹤0.01% 3200
2013
Q3
$1.99M Buy
20,026
+9,393
+88% +$933K ﹤0.01% 3218
2013
Q2
$406K Buy
+10,633
New +$406K ﹤0.01% 4404